VanEck Biotech ETF (NASDAQ:BBH) Sees Large Drop in Short Interest

VanEck Biotech ETF (NASDAQ:BBH) was the target of a significant decline in short interest in the month of January. As of January 30th, there was short interest totaling 6,883 shares, a decline of 63.1% from the January 15th total of 18,670 shares. Based on an average daily volume of 7,434 shares, the short-interest ratio is currently 0.9 days. Approximately 0.3% of the shares of the company are sold short. Approximately 0.3% of the shares of the company are sold short. Based on an average daily volume of 7,434 shares, the short-interest ratio is currently 0.9 days.

Institutional Trading of VanEck Biotech ETF

A number of hedge funds and other institutional investors have recently modified their holdings of BBH. Huntington National Bank bought a new stake in shares of VanEck Biotech ETF during the 4th quarter valued at $132,000. Bleakley Financial Group LLC increased its stake in VanEck Biotech ETF by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 17,752 shares of the company’s stock worth $3,360,000 after buying an additional 223 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in VanEck Biotech ETF by 40,463.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 494,061 shares of the company’s stock valued at $93,506,000 after acquiring an additional 492,843 shares during the period. Allworth Financial LP raised its holdings in VanEck Biotech ETF by 255.0% during the fourth quarter. Allworth Financial LP now owns 426 shares of the company’s stock valued at $81,000 after acquiring an additional 306 shares during the period. Finally, Wealthfront Advisers LLC lifted its position in shares of VanEck Biotech ETF by 2.3% in the fourth quarter. Wealthfront Advisers LLC now owns 5,513 shares of the company’s stock valued at $1,043,000 after acquiring an additional 122 shares in the last quarter. 32.05% of the stock is owned by hedge funds and other institutional investors.

VanEck Biotech ETF Stock Down 1.1%

NASDAQ BBH opened at $195.86 on Wednesday. VanEck Biotech ETF has a 52 week low of $135.34 and a 52 week high of $202.91. The stock’s 50-day moving average price is $193.64 and its 200-day moving average price is $180.51.

VanEck Biotech ETF Announces Dividend

The company also recently announced an annual dividend, which was paid on Friday, December 26th. Shareholders of record on Monday, December 22nd were paid a dividend of $0.9565 per share. The ex-dividend date was Monday, December 22nd. This represents a yield of 50.0%.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.